De novo tryptophanase-based indole production by metabolically engineered Corynebacterium glutamicum
Applied Microbiology and Biotechnology · 2023
DOI: 10.1007/s00253-023-12397-4 ↗Kurz gefasst
Fachartikel in der Zeitschrift Applied Microbiology and Biotechnology, 2023. Verfasst von Melanie Mindt und 4 weiteren Autor:innen. Beteiligte Einrichtung: Wageningen Plant Research, Business Unit Bioscience, Wageningen University & Research, Wageningen, The Netherlands. Hauptthemen laut MEDLINE: Tryptophanase, Corynebacterium glutamicum. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 66 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Horizon 2020 Framework Programme, FNR, NWO.
Abstract (Originalsprache)
Indole has an increasing interest in the flavor and fragrance industry. It is used in dairy products, tea drinks, and fine fragrances due to its distinct floral odor typical of jasmine blossoms. The current production of indole based on isolation from coal tar is non-sustainable and its isolation from plants is often unprofitable due to low yields. To offer an alternative to the conventional production, biosynthesis of indole has been studied recently. A glucose-based indole production was achieved by employing the Corynebacterium glutamicum tryptophan synthase α-subunit (TrpA) or indole-3-glycerol phosphate lyase (IGL) from wheat Triticum aestivum in a genetically-engineered C. glutamicum strain. In addition, a highly efficient bioconversion process using C. glutamicum heterologously expressing tryptophanase gene ( tnaA ) from Providencia rettgeri as a biocatalyst was developed. In this work, de novo indole production from glucose was enabled by expressing the P. rettgeri tnaA in a tryptophan-producing C. glutamicum strain. By metabolic engineering of a C. glutamicum shikimate accumulating base strain, tryptophan production of 2.14 ± 0.02 g L -1 was achieved. Introduction of the tryptophanase form P. rettgeri enabled indole production, but to low titers, which could be improved by sequestering indole into the water-immiscible solvent tributyrin during fermentation and a titer of 1.38 ± 0.04 g L -1 was achieved. The process was accelerated by decoupling growth from production increasing the volumetric productivity about 4-fold to 0.08 g L -1 h -1 . Key points • Efficient de novo indole production via tryptophanases from glucose • Increased indole titers by product sequestration and improved precursor supply • Decoupling growth from production accelerated indole production
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Wageningen Plant Research, Business Unit Bioscience, Wageningen University & Research, Wageningen, The Netherlands.
- Axxence Aromatic GmbH, Emmerich am Rhein, Germany.
- Genetics of Prokaryotes, Faculty of Biology & CeBiTec, Bielefeld University, Bielefeld, Germany.
- Translational Pharmacology, Faculty of Medicine OWL, Bielefeld University, Bielefeld, Germany.
- Wageningen Plant Research, Business Unit Bioscience, Wageningen University & Research, Wageningen, The Netherlands. katarina.cankar@wur.nl.
- Genetics of Prokaryotes, Faculty of Biology & CeBiTec, Bielefeld University, Bielefeld, Germany. volker.wendisch@uni-bielefeld.de.
Förderung
- Horizon 2020 Framework Programme
- FNR
- NWO
Zitieren
APA
Mindt, M., Ferrer, L., Bosch, D., Cankar, K., & Wendisch, V. F. (2023). De novo tryptophanase-based indole production by metabolically engineered Corynebacterium glutamicum. Applied Microbiology and Biotechnology. https://doi.org/10.1007/s00253-023-12397-4
Vancouver
Mindt M, Ferrer L, Bosch D, Cankar K, Wendisch VF. De novo tryptophanase-based indole production by metabolically engineered Corynebacterium glutamicum. Applied Microbiology and Biotechnology. 2023. doi:10.1007/s00253-023-12397-4
BibTeX
@article{Mindt2023,
author = {Mindt, Melanie and Ferrer, Lenny and Bosch, Dirk and Cankar, Katarina and Wendisch, Volker F},
title = {De novo tryptophanase-based indole production by metabolically engineered Corynebacterium glutamicum},
journal = {Applied Microbiology and Biotechnology},
year = {2023},
doi = {10.1007/s00253-023-12397-4}
}
EUVIMED